# METFORMIN HYDROCHLORIDE
> **ANDA213334** · Abbreviated New Drug Application (Generic) · Sponsor: SCIEGEN PHARMS · Approved 2021-04-16
## Drug
- **FDA Application Number:** ANDA213334
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** METFORMIN HYDROCHLORIDE
- **Generic name:** METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS
- **Active ingredients:** METFORMIN HYDROCHLORIDE
- **Dosage form:** TABLET, EXTENDED RELEASE
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** SCIEGEN PHARMS
- **Manufacturer:** ScieGen Pharmaceuticals, Inc.
- **First approval:** 2021-04-16
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=213334)
---
*MORVS · CC0 1.0*